{
  "DOI": "10.1007/s10689-017-0050-6",
  "ISSN": [
    "1389-9600",
    "1573-7292"
  ],
  "URL": "http://dx.doi.org/10.1007/s10689-017-0050-6",
  "alternative-id": [
    "50"
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Myszka",
      "given": "Aleksander",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Nguyen-Dumont",
      "given": "Tu",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Karpinski",
      "given": "Pawel",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Sasiadek",
      "given": "Maria M.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Akopyan",
      "given": "Hayane",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Hammet",
      "given": "Fleur",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Tsimiklis",
      "given": "Helen",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Park",
      "given": "Daniel J.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Pope",
      "given": "Bernard J.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Slezak",
      "given": "Ryszard",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Kitsera",
      "given": "Nataliya",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Siekierzynska",
      "given": "Aleksandra",
      "sequence": "additional"
    },
    {
      "ORCID": "http://orcid.org/0000-0002-6313-9005",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Southey",
      "given": "Melissa C.",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Familial Cancer"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2017,
        10,
        19
      ]
    ],
    "date-time": "2017-10-19T04:05:52Z",
    "timestamp": 1508385952000
  },
  "deposited": {
    "date-parts": [
      [
        2018,
        6,
        13
      ]
    ],
    "date-time": "2018-06-13T07:32:00Z",
    "timestamp": 1528875120000
  },
  "funder": [
    {
      "DOI": "10.13039/501100000925",
      "award": [
        "APP1029974",
        "APP1074383",
        "APP1061177"
      ],
      "doi-asserted-by": "publisher",
      "name": "National Health and Medical Research Council"
    },
    {
      "award": [
        "VR0182"
      ],
      "name": "VLSCI"
    },
    {
      "award": [
        "UDA-POKL.04.01.01-00-068/10-00"
      ],
      "name": "European Social Fund, Human Capital, national Cohesion Strategy"
    },
    {
      "DOI": "10.13039/501100001026",
      "doi-asserted-by": "publisher",
      "name": "National Breast Cancer Foundation"
    }
  ],
  "indexed": {
    "date-parts": [
      [
        2023,
        10,
        30
      ]
    ],
    "date-time": "2023-10-30T17:42:40Z",
    "timestamp": 1698687760455
  },
  "is-referenced-by-count": 8,
  "issn-type": [
    {
      "type": "print",
      "value": "1389-9600"
    },
    {
      "type": "electronic",
      "value": "1573-7292"
    }
  ],
  "issue": "3",
  "issued": {
    "date-parts": [
      [
        2017,
        10,
        19
      ]
    ]
  },
  "journal-issue": {
    "issue": "3",
    "published-print": {
      "date-parts": [
        [
          2018,
          7
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "http://creativecommons.org/licenses/by/4.0",
      "content-version": "unspecified",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2017,
            10,
            19
          ]
        ],
        "date-time": "2017-10-19T00:00:00Z",
        "timestamp": 1508371200000
      }
    }
  ],
  "link": [
    {
      "URL": "http://link.springer.com/article/10.1007/s10689-017-0050-6/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s10689-017-0050-6.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s10689-017-0050-6.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "345-349",
  "prefix": "10.1007",
  "published": {
    "date-parts": [
      [
        2017,
        10,
        19
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2017,
        10,
        19
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2018,
        7
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1186/s13053-016-0049-2",
      "author": "MC Southey",
      "doi-asserted-by": "publisher",
      "first-page": "9",
      "journal-title": "Hered Cancer Clin Pract",
      "key": "50_CR1",
      "unstructured": "Southey MC, Winship I, Nguyen-Dumont T (2016) PALB2: research reaching to clinical outcomes for women with breast cancer. Hered Cancer Clin Pract 14:9. doi:\n10.1186/s13053-016-0049-2",
      "volume": "14",
      "year": "2016"
    },
    {
      "DOI": "10.1086/375033",
      "author": "A Antoniou",
      "doi-asserted-by": "crossref",
      "first-page": "1117",
      "issue": "5",
      "journal-title": "Am J Hum Genet",
      "key": "50_CR2",
      "unstructured": "Antoniou A, Pharoah PDP, Narod S et al (2003) Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 72(5):1117–1130",
      "volume": "72",
      "year": "2003"
    },
    {
      "DOI": "10.1056/NEJMoa1400382",
      "author": "AC Antoniou",
      "doi-asserted-by": "publisher",
      "first-page": "497",
      "issue": "6",
      "journal-title": "N Engl J Med",
      "key": "50_CR3",
      "unstructured": "Antoniou AC, Casadei S, Heikkinen T et al (2014) Breast-cancer risk in families with mutations in PALB2. N Engl J Med 371(6):497–506. doi:\n10.1056/NEJMoa1400382",
      "volume": "371",
      "year": "2014"
    },
    {
      "DOI": "10.1136/jmedgenet-2016-103839",
      "author": "MC Southey",
      "doi-asserted-by": "publisher",
      "journal-title": "J Med Genet",
      "key": "50_CR4",
      "unstructured": "Southey MC, Goldgar DE, Winqvist R et al (2016) PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS. J Med Genet. doi:\n10.1136/jmedgenet-2016-103839",
      "year": "2016"
    },
    {
      "DOI": "10.1016/S1470-2045(15)70142-7",
      "author": "C Cybulski",
      "doi-asserted-by": "publisher",
      "first-page": "638",
      "issue": "6",
      "journal-title": "Lancet Oncol",
      "key": "50_CR5",
      "unstructured": "Cybulski C, Kluzniak W, Huzarski T et al (2015) Clinical outcomes in women with breast cancer and a PALB2 mutation: a prospective cohort analysis. Lancet Oncol 16(6):638–644. doi:\n10.1016/S1470-2045(15)70142-7",
      "volume": "16",
      "year": "2015"
    },
    {
      "DOI": "10.1007/s10897-007-9090-7",
      "author": "JL Berliner",
      "doi-asserted-by": "publisher",
      "first-page": "241",
      "issue": "3",
      "journal-title": "J Genet Couns",
      "key": "50_CR6",
      "unstructured": "Berliner JL, Fay AM, Practice Issues Subcommittee of the National Society of Genetic Counselors’ Familial Cancer Risk Counseling Special Interest G (2007) Risk assessment and genetic counseling for hereditary breast and ovarian cancer: recommendations of the National Society of Genetic Counselors. J Genet Couns 16(3):241–260. doi:\n10.1007/s10897-007-9090-7",
      "volume": "16",
      "year": "2007"
    },
    {
      "DOI": "10.1007/s10549-014-3260-8",
      "author": "T Nguyen-Dumont",
      "doi-asserted-by": "crossref",
      "first-page": "547",
      "issue": "2",
      "journal-title": "Breast Cancer Res Treat",
      "key": "50_CR7",
      "unstructured": "Nguyen-Dumont T, Hammet F, Mahmoodi M et al (2015) Mutation screening of PALB2 in clinically ascertained families from the Breast Cancer Family Registry. Breast Cancer Res Treat 149(2):547–554",
      "volume": "149",
      "year": "2015"
    },
    {
      "DOI": "10.1186/1751-0473-9-3",
      "author": "BJ Pope",
      "doi-asserted-by": "publisher",
      "first-page": "3",
      "issue": "1",
      "journal-title": "Source Code Biol Med",
      "key": "50_CR8",
      "unstructured": "Pope BJ, Nguyen-Dumont T, Hammet F, Park DJ (2014) ROVER variant caller: read-pair overlap considerate variant-calling software applied to PCR-based massively parallel sequencing datasets. Source Code Biol Med 9(1):3. doi:\n10.1186/1751-0473-9-3",
      "volume": "9",
      "year": "2014"
    },
    {
      "DOI": "10.1186/s/3073-015-0195-6",
      "doi-asserted-by": "publisher",
      "key": "50_CR9",
      "unstructured": "Münz M, Ruark E, Renwick A et al (2015) CSN and CAVA: variant annotation tools for rapid, robust next-generation sequencing analysis in the clinic. Genome Med 7:76. doi:\n                        10.1186/s/3073-015-0195-6"
    },
    {
      "DOI": "10.1002/0471142905.hg0720s76",
      "author": "I Adzhubei",
      "doi-asserted-by": "publisher",
      "journal-title": "Curr Protoc Hum Genet",
      "key": "50_CR10",
      "unstructured": "Adzhubei I, Jordan DM, Sunyaev SR (2013) Predicting functional effect of human missense mutations using PolyPhen-2. Curr Protoc Hum Genet. doi:\n10.1002/0471142905.hg0720s76",
      "year": "2013"
    },
    {
      "DOI": "10.1038/ng.2892",
      "author": "M Kircher",
      "doi-asserted-by": "publisher",
      "first-page": "310",
      "issue": "3",
      "journal-title": "Nat Genet",
      "key": "50_CR11",
      "unstructured": "Kircher M, Witten DM, Jain P, O’Roak BJ, Cooper GM, Shendure J (2014) A general framework for estimating the relative pathogenicity of human genetic variants. Nat Genet 46(3):310–315. doi:\n10.1038/ng.2892",
      "volume": "46",
      "year": "2014"
    },
    {
      "DOI": "10.1101/030338",
      "author": "M Lek",
      "doi-asserted-by": "publisher",
      "journal-title": "bioRxiv",
      "key": "50_CR12",
      "unstructured": "Lek M, Karczewski K, Minikel E et al (2015) Analysis of protein-coding genetic variation in 60,706 humans. bioRxiv. doi:\n10.1101/030338",
      "year": "2015"
    },
    {
      "DOI": "10.1186/1471-2350-11-20",
      "author": "A Dansonka-Mieszkowska",
      "doi-asserted-by": "publisher",
      "first-page": "20",
      "journal-title": "BMC Med Genet",
      "key": "50_CR13",
      "unstructured": "Dansonka-Mieszkowska A, Kluska A, Moes J et al (2010) A novel germline PALB2 deletion in Polish breast and ovarian cancer patients. BMC Med Genet 11:20. doi:\n10.1186/1471-2350-11-20",
      "volume": "11",
      "year": "2010"
    },
    {
      "DOI": "10.1158/1055-9965.EPI-13-0745-T",
      "author": "M Janatova",
      "doi-asserted-by": "publisher",
      "first-page": "2323",
      "issue": "12",
      "journal-title": "Cancer Epidemiol Prev Biomark",
      "key": "50_CR14",
      "unstructured": "Janatova M, Kleibl Z, Stribrna J et al (2013) The PALB2 gene is a strong candidate for clinical testing in BRCA1- and BRCA2-negative hereditary breast cancer. Cancer Epidemiol Prev Biomark 22(12):2323–2332. doi:\n10.1158/1055-9965.EPI-13-0745-T",
      "volume": "22",
      "year": "2013"
    },
    {
      "DOI": "10.1186/s13053-016-0046-5",
      "author": "P Wojcik",
      "doi-asserted-by": "publisher",
      "first-page": "5",
      "journal-title": "Hereditary Cancer Clin Practice",
      "key": "50_CR15",
      "unstructured": "Wojcik P, Jasiowka M, Strycharz E et al (2016) Recurrent mutations of BRCA1, BRCA2 and PALB2 in the population of breast and ovarian cancer patients in Southern Poland. Hereditary Cancer Clin Practice 14:5. doi:\n10.1186/s13053-016-0046-5",
      "volume": "14",
      "year": "2016"
    },
    {
      "DOI": "10.1007/s10689-013-9684-1",
      "author": "M Noskowicz",
      "doi-asserted-by": "publisher",
      "first-page": "137",
      "issue": "2",
      "journal-title": "Fam Cancer",
      "key": "50_CR16",
      "unstructured": "Noskowicz M, Bogdanova N, Bermisheva M et al (2014) Prevalence of PALB2 mutation c.509_510delGA in unselected breast cancer patients from Central and Eastern Europe. Fam Cancer 13(2):137–142. doi:\n10.1007/s10689-013-9684-1",
      "volume": "13",
      "year": "2014"
    },
    {
      "DOI": "10.1111/cge.12524",
      "author": "C Cybulski",
      "doi-asserted-by": "publisher",
      "first-page": "366",
      "issue": "4",
      "journal-title": "Clin Genet",
      "key": "50_CR17",
      "unstructured": "Cybulski C, Lubinski J, Wokolorczyk D et al (2015) Mutations predisposing to breast cancer in 12 candidate genes in breast cancer patients from Poland. Clin Genet 88(4):366–370. doi:\n10.1111/cge.12524",
      "volume": "88",
      "year": "2015"
    },
    {
      "DOI": "10.2217/bmm.13.143",
      "author": "SV Tavtigian",
      "doi-asserted-by": "publisher",
      "first-page": "589",
      "issue": "4",
      "journal-title": "Biomark Med",
      "key": "50_CR18",
      "unstructured": "Tavtigian SV, Chenevix-Trench G (2014) Growing recognition of the role for rare missense substitutions in breast cancer susceptibility. Biomark Med 8(4):589–603. doi:\n10.2217/bmm.13.143",
      "volume": "8",
      "year": "2014"
    },
    {
      "DOI": "10.1002/humu.22022",
      "author": "M Tischkowitz",
      "doi-asserted-by": "publisher",
      "first-page": "674",
      "issue": "4",
      "journal-title": "Hum Mutat",
      "key": "50_CR19",
      "unstructured": "Tischkowitz M, Capanu M, Sabbaghian N et al (2012) Rare germline mutations in PALB2 and breast cancer risk: a population-based study. Hum Mutat 33(4):674–680. doi:\n10.1002/humu.22022",
      "volume": "33",
      "year": "2012"
    }
  ],
  "reference-count": 19,
  "references-count": 19,
  "resource": {
    "primary": {
      "URL": "http://link.springer.com/10.1007/s10689-017-0050-6"
    }
  },
  "score": 0,
  "short-container-title": [
    "Familial Cancer"
  ],
  "source": "Crossref",
  "title": [
    "Targeted massively parallel sequencing characterises the mutation spectrum of PALB2 in breast and ovarian cancer cases from Poland and Ukraine"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "17"
}